drugset / Trial / NCT00615836
An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to investigate the long term efficacy and safety of several doses of the Melt formulation of desmopressin in a broad population of adult patients with nocturia.
Timeline
- Start
- 2007-12
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | 10 ug | Other |
| Subject | Desmopressin | Peptide | 25 ug | Other |
| Subject | Desmopressin | Peptide | 50 ug | Other |
| Subject | Desmopressin | Peptide | 100 ug | Other |